Back to search
FDAFDA · Food and drugs·Recall number D-1405-2012

Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5% (from Coal Tar USP Solution, 7%), 7.5 oz bottle, Distributed by Ranbaxy, Jacksonville, FL 32257, NDC 10631-106-08

Published July 11, 2012 · Recall initiated: March 16, 2012

Summary

FDA records drug Class III recall D-1405-2012, published July 11, 2012 and initiated March 16, 2012. Recalling firm: Ranbaxy Inc.; Status: Terminated; Reported quantity: 2544 bottles; Lot: Lot #: RB81031, Exp 01/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ranbaxy Inc.
Distributor
Nationwide
Lot
Lot #: RB81031, Exp 01/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5% (from Coal Tar USP Solution, 7%), 7.5 oz bottle, Distributed by Ranbaxy, Jacksonville, FL 32257, NDC 10631-106-08 recalled?

Yes. FDA published recall D-1405-2012 on July 11, 2012. Reported hazard: Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter